Literature DB >> 27494928

Mosaic tetracycline resistance genes encoding ribosomal protection proteins.

Philip J Warburton1, Nina Amodeo2, Adam P Roberts3.   

Abstract

First reported in 2003, mosaic tetracycline resistance genes are a subgroup of the genes encoding ribosomal protection proteins (RPPs). They are formed when two or more RPP-encoding genes recombine resulting in a functional chimera. To date, the majority of mosaic genes are derived from sections of three RPP genes, tet(O), tet(W) and tet(32), with others comprising tet(M) and tet(S). In this first review of mosaic genes, we report on their structure, diversity and prevalence, and suggest that these genes may be responsible for an under-reported contribution to tetracycline resistance in bacteria.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27494928      PMCID: PMC5181394          DOI: 10.1093/jac/dkw304

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


Introduction

Tetracyclines bind to the A-site on the bacterial ribosome, resulting in steric blocking of the aminoacyl-tRNA binding site, which prevents protein synthesis.[1] They are effective against both Gram-positive and Gram-negative bacteria and, due to the relative lack of major side effects and cheap cost, have been used extensively in the treatment of infections[2] as well as growth promoters in animal husbandry.[3] Bacterial resistance to tetracycline is often mediated through the acquisition of DNA encoding proteins that confer resistance by one of three main mechanisms: ATP-dependent efflux, enzymatic inactivation of tetracycline, or ribosomal protection.[2] To date, a total of 60 different classes of tetracycline resistance gene, including oxytetracycline resistance genes, have been reported. These include 33 predicted or proven to encode active efflux pumps, 12 encoding ribosomal protection proteins (RPPs), 13 encoding inactivating enzymes and 1 reported to confer resistance via an as yet undetermined mechanism, designated tet(U) (a full list is periodically updated by Roberts[4]). Although it has yet to be assigned a mechanistic class, tet(U) has been identified in Enterococcus and Staphylococcus isolates.[5,6] However, a study by Caryl et al.[7] reported that when tet(U) was cloned and expressed in Escherichia coli, the transformants were not resistant to tetracycline. To be considered a new class of tetracycline resistance gene, it must encode a protein <80% identical to known tetracycline resistance proteins.[8] Determinants representing new classes were originally assigned a letter from the English alphabet.[9] However, as all letters are used, they are now assigned an Arabic numeral,[8] with new determinants referred to the Levy group (bonnie.marshall@tufts.edu) in order to obtain a designation prior to publication to avoid duplication and ensure taxonomic consistency.

RPPs

RPPs are a related group of proteins that, when bound to the ribosome, result in the release of tetracycline from the ribosome, enabling protein synthesis to proceed[10] (reviewed by Thaker et al.[11]). Of the 12 classes of RPP gene currently reported [tet(M), (O), (Q), (S), (T), (W), (32), (36), (44), B(P), otr(A) and tet], tet(M) is considered the most prevalent due to its association with the broad host range Tn916/Tn1545 family of conjugative transposons.[12] However, a subgroup of RPP genes has been identified that consist of regions of different, already characterized RPP genes that appear to have undergone recombination forming a mosaic gene. It must be stressed here that the progenitors of mosaic genes are assumed based purely on the order in which they were discovered and we cannot be sure of the directionality of mosaic gene formation.

Mosaic RPP genes

In 2003, Stanton and Humphery[13] reported two RPP genes in Megasphaera elsdenii that encoded predicted proteins showing 89.1% and 91.9% identity to Tet(W) (accession number AJ222769) from Butyrivibrio fibrisolvens. As this was above the <80% cut-off, they did not qualify as a new resistance class under the nomenclature system. However, further analysis of the amino acid sequence revealed variability in the percentage identity to Tet(W) across its length. The large central section in both sequences showed 98.1% identity to Tet(W), while small sections at the N- and C-terminal ends were found to have a lower amino acid sequence identity to Tet(W) [between 66.6% and 75.3%]. However, these same N- and C-terminal sections were shown to have between 99.3% and 100% amino acid identity to Tet(O) (accession number M18896), despite the central section showing identity to Tet(W). Given the evidence, this suggested recombination had occurred, creating a mosaic determinant with a central Tet(W) region flanked by two Tet(O) regions. Although never before observed between two different RPP classes, recombination resulting in functional genes has previously been reported between different phylotypes of tet(M)[14] as well as in other antibiotic resistance genes, such as penA and pbp2x, which confer resistance to penicillin.[15,16] Furthermore, in vitro experiments have successfully recombined tet(A) and tet(C) to create mosaics that confer resistance to tetracycline at levels comparable to the non-mosaic tet(C).[17] The guideline for determining a new resistance gene class was established prior to the discovery of these mosaic RPP genes and none of the mosaic genes qualified as a new class when analysed as one single continuous sequence. It was clear, however, that these mosaic genes were different from their non-mosaic counterparts and that the current classification did not adequately reflect the true evolutionary background of these genes. Therefore, an expansion of the nomenclature system was suggested whereby the mosaic gene would receive a designation that reflected the structural order and class of the genes they comprised, better reflecting their variable nature.[18,19] For example, the two resistance genes reported in M. elsdenii, which comprised a central tet(W) region flanked by two tet(O) regions, were designated tet(O/W/O).[13] Although Stanton and Humphrey[13] were the first to report mosaic RPP genes, Melville et al.[20] had unknowingly reported a mosaic gene 2 years previously. This resistance gene, found in Clostridium saccharolyticum K10, encoded a predicted protein that showed 76% amino acid identity to Tet(O) (accession number Y07780). As per the original nomenclature guidelines, it was given the new designation Tet(32). However, subsequent re-examination of the sequence found that only the central section showed <80% identity to known proteins, while the N- and C-terminal regions flanking the central section shared 100% and 97.7% identity, respectively, to Tet(O) (accession number M18896). The central region was still thought to represent a section of a new Tet(32) class and therefore the determinant was reclassified Tet(O/32/O).[18] Subsequently, the proposed full, non-mosaic sequences of Tet(32) have been reported in several isolates identified from the human oral cavity,[21,22] with the Tet(O/32/O) mosaic determinant now showing 89% amino acid identity to these. Similarly, the previously reported tet(S) allele (accession number AY534326) on the conjugative transposon Tn916S[23] has subsequently been reclassified as a result of in silico analysis. The amino acid sequence shows identity to Tet(S) across 595 amino acids (1–595 inclusive), with the final 61 amino acids at the C-terminus end identical to Tet(M) (accession number U09422), resulting in it being reclassified as Tet(S/M).[24]

Mosaic gene diversity

To date, a total of 30 mosaic genes have been reported in the literature, of which 26 currently have sequences deposited in GenBank (Table 1). Some studies have reported multiple occurrences of known genes; however, many of these have been characterized by PCR amplification only. Structurally, these chimeric genes currently comprise either two [e.g. tet(O/W)], three [e.g. tet(O/W/O)], four [e.g. tet(O/W/32/O)] or six [e.g. tet(O/W/32/O/W/O)] different regions (Figure 1), with tet(O), tet(W) and tet(32) being the predominant RPP genes reported to form mosaic genes, comprising all but two of the reported variants, and tet(M) and tet(S) forming the remaining two.[24,25] Given the prevalence of tet(M) in certain samples, and the previous reports of self-recombination,[14,26] it is surprising that there are so few reports of mosaic genes containing tet(M). Furthermore, alignment of 12 representative RPP gene sequences shows tet(M) sharing 75% and 70% identity, respectively, to tet(O) and tet(44), which is higher than the percentage identity observed between the more commonly reported RPP mosaic genes comprising tet(O), (W) and (32) (Table 2). However, mosaic genes comprising tet(M) and any other gene, with the exception of tet(S), have yet to be reported. It is entirely possible that this may be due to a lack of investigation rather than an absence of recombination followed by fixation of the recombinant allele in the bacterial population. Alternatively, it is possible that there is little selective pressure for tet(M)-based mosaic genes if the resultant protein is no more efficient than Tet(M) itself and/or there is no indirect selective pressure for mosaicism. A similar situation may exist for other proteins, such as Tet(S). Stanton et al.[27] reported that the protein encoded by the tet(O/W/O) mosaic genes in M. elsdenii conferred a higher level of resistance to tetracycline than their non-mosaic counterparts, but similar investigations are still to be reported for other RPP genes. Therefore, the prevalence of certain mosaic gene variants could suggest that they are in some way more beneficial to the host than the non-mosaic genes they comprise.
Table 1.

A summary of the mosaic tetracycline genes reported to date

GeneOrganismSource(s)Accession numberReference(s)
tet(O/W)Bifidobacterium thermophilum B0219environmental (pig slaughterhouse) sampleAM88911832
tet(O/W)B. thermophilum B0241pig faecesAM88911932
tet(O/W)B. thermophilum B0242pig faecesAM88912032
tet(O/W)B. thermophilum B0253pig faecesAM88912132
tet(O/W)B. thermophilum B0256pig faecesAM88912232
tet(O/W)-2Megasphaera elsdenii 25-51swine faecesAY48512218,27
tet(O/W)-1 [n = 15a]M. elsdenii 27-51swine faecesAY48512627,33
tet(O/W/O)-4uncultured bacterial clonepig faecesno accession number21
tet(O/W/O)-3 [n = 9]uncultured bacterial clonepig faecesEF06552421
tet(O/W/O)-2 [n = 28b]M. elsdenii 14-14swine caecumAY19692013,18,27,33
tet(O/W/O)-1 [n = 2]M. elsdenii 7-11swine caecumAY19692113,18,27
tet(O/W/32/O) [n = 32]uncultured bacterial clonepig faecesEF06552321
tet(O/W/32/O) [n = 7c]Streptococcus suis Ss1303pig (brain, lung and spleen) and human (CSF) samplesFM16439234
tet(O/W/32/O)S. suis 32457diseased pig lungFR82330434,35
tet(O/W/32/O)Streptococcus gallolyticus subsp. gallolyticus ATCC 2069 plasmid pSGG1human bloodFR82404436
tet(O/W/32/O)S. suisdiseased pig (blood, brain, heart, joint and lung) samplesJQ74005328
tet(O/W/32/O/W/O)Lactobacillus johnsonii G41human faecesDQ52502332
tet(O/W/32/O/W/O)uncultured bacterial clonepig faecesDQ67992621
tet(O/32/O)S. suisdiseased pig (blood, brain, heart, joint and lung) samplesJQ74005228
tet(O/32/O)Clostridium saccharolyticum K10human colonAJ29523818
tet(O/32/O)-2 [n = 3]uncultured bacterial clonehuman and animal faecal samplesno accession number21
tet(O/32/O)-3uncultured bacterial clonehuman and animal faecal samplesno accession number21
tet(O/32/O)-4uncultured bacterial clonehuman and animal faecal samplesno accession number21
tet(O/32/O)-5uncultured bacterial clonehuman and animal faecal samplesno accession number21
tet(O/32/O)Dorea longicatena AGR2136rumen microbiomeNZ_AUJS01000017 (41 626–43 545 bp)direct submission, analysed in this study
tet(O/32/O)Campylobacter coli 202/04human faecesAINH01000038 (2361–4280 bp)direct submission, analysed in this study
tet(O/32/O)C. coli 317/04human faecesNZ_AINJ01000054 (2094–4013 bp)direct submission, analysed in this study
tet(O/32/O)Campylobacter jejuni subspecies jejuni 2008-894humanAIOQ01000025 (14 515–16 434 bp)direct submission, analysed in this study
tet(O/32/O)Roseburia intestinalis XB6B4human intestinal tractFP929050 (2 873 814–2 875 733 bp)direct submission, analysed in this study
tet(S/M)Streptococcus equinus 1357foodHM36771125
tet(S/M)Streptococcus intermediushuman isolateAY53432623,24
tet(W/32/O)B. thermophilum B0219environmental (pig slaughterhouse) sampleAM71060132
tet(W/32/O)B. thermophilum B0241pig faecesAM71060232
tet(W/32/O)B. thermophilum B0242pig faecesAM71060332
tet(W/32/O)B. thermophilum B0253pig faecesAM71060432
tet(W/32/O)B. thermophilum B0256pig faecesAM71060532

The number given in square brackets indicates the instances of that mosaic gene variant reported, if more than one.

aFourteen of the 15 tet(O/W)-1 variants were only determined by PCR analysis and so could be either tet(O/W)-1 or tet(O/W)-2.

bEleven of the 28 tet(O/W/O)-2 variants were only determined by PCR analysis and so could be either tet(O/W/O)-2 or tet(O/W/O)-1.

cAll S. suis isolates, but not the same strain.

Figure 1.

Schematic representation of reported mosaic tetracycline RPP genes. The coded bars indicate sequences of high identity to specific RPP genes: vertical line bars for tet(M), white bars for tet(O), grey bars for tet(S), black bars for tet(W) and checked bars for tet(32). The number above the bar indicates the reported crossover point. aIndicates those sequences that are incomplete or absent in GenBank, with the crossover points taken from the publication. bIndicates sequences that have been analysed in this study due to no specific crossover point(s) reported.

Table 2.

Sequence identity matrix showing the percentage nucleotide identity between representatives of all 12 RPP gene classes, in descending order, compared with tet(M)

RPP genetet(M)tet(S)tet(O)tet(44)tet(32)tet(W)tet(T)tet(36)tet(Q)tetB(P)otr(A)tet
tet(M)1007875706964574946231111
tet(S)10070696762565648111110
tet(O)100696965564948151211
tet(44)1007164505846151110
tet(32)10067554947111210
tet(W)10012451551412
tet(T)10057561882
tet(36)1006491111
tet(Q)100131212
tetB(P)10011
otr(A)10063
tet100

Accession numbers of representative genes included in the matrix: tet(M), U09422; tet(O), Y07780; tetB(P), AE001437; tet(Q), X58717; tet(S), X92946; tet(T), L42544; tet(W), AJ222769; tet(32), DQ647324; tet(36), AJ514254; tet(44), FN594949; otr(A), X53401; tet, AL939106.

Shaded boxes represent those genes currently reported to comprise mosaic genes.

A summary of the mosaic tetracycline genes reported to date The number given in square brackets indicates the instances of that mosaic gene variant reported, if more than one. aFourteen of the 15 tet(O/W)-1 variants were only determined by PCR analysis and so could be either tet(O/W)-1 or tet(O/W)-2. bEleven of the 28 tet(O/W/O)-2 variants were only determined by PCR analysis and so could be either tet(O/W/O)-2 or tet(O/W/O)-1. cAll S. suis isolates, but not the same strain. Sequence identity matrix showing the percentage nucleotide identity between representatives of all 12 RPP gene classes, in descending order, compared with tet(M) Accession numbers of representative genes included in the matrix: tet(M), U09422; tet(O), Y07780; tetB(P), AE001437; tet(Q), X58717; tet(S), X92946; tet(T), L42544; tet(W), AJ222769; tet(32), DQ647324; tet(36), AJ514254; tet(44), FN594949; otr(A), X53401; tet, AL939106. Shaded boxes represent those genes currently reported to comprise mosaic genes. Schematic representation of reported mosaic tetracycline RPP genes. The coded bars indicate sequences of high identity to specific RPP genes: vertical line bars for tet(M), white bars for tet(O), grey bars for tet(S), black bars for tet(W) and checked bars for tet(32). The number above the bar indicates the reported crossover point. aIndicates those sequences that are incomplete or absent in GenBank, with the crossover points taken from the publication. bIndicates sequences that have been analysed in this study due to no specific crossover point(s) reported.

PCR-based analysis

PCR-based assays have been developed to help researchers detect specific mosaic genes. Stanton and Humphrey[13] describe an assay that distinguished between the non-mosaic genes tet(O) and tet(W) and the mosaic tet(O/W/O) from Megasphaera strains, enabling them to detect tet(O/W/O) variants in six additional M. elsdenii strains. Patterson et al.[21] investigated the presence of mosaic genes using various specific oligonucleotide sets that either bound within the resistance genes or flanked them. Amplicons specific to tet(O/W), tet(O/32) and tet(W/32) were detected in faecal samples, with tet(O/32) being the most common of these mosaic amplicons; it was amplified in all 12 pig faecal samples and 6 of 7 human faecal samples tested. In contrast, the faecal samples from cows and sheep, as well as human saliva samples, failed to produce any amplicons for these mosaic genes, suggesting they were not present at detectable levels. Chen et al.[28] also used an oligonucleotide primer set that annealed outside tet(O) to determine the presence of tetracycline resistance genes in two Streptococcus suis isolates. Although no amplicon was produced using internal, tet(O)-specific primers, the primers binding to flanking DNA yielded an amplicon, indicating the presence of mosaic genes [identified as tet(O/32/O) and tet(O/W/32/O)]. This full-length oligonucleotide primer set does aid the identification of mosaic genes; however, it is only specific for those with regions homologous to tet(O) flanking sequences. Since PCR strategies aimed at identifying resistance genes require knowledge of the sequence of the target, mosaic RPP genes are likely to be largely undetected and under-reported by PCR-based studies. Reflecting the findings by Patterson et al.,[21] almost all the mosaic genes reported to date have originated from faecal samples, with the majority identified from a porcine origin and less commonly from humans (Table 1). The gut houses a complex and diverse bacterial community with potential for widespread horizontal gene transfer, and the mosaic genes found in faecal samples are likely to reflect the pool of non-mosaic genes present within the gut microbiota. Genes such as tet(W) and tet(O) are commonly reported from these types of samples,[29] but the prevalence of tet(32)-containing mosaic genes suggests that tet(32) may be more common than initially thought. In fact, tet(O/32/O) was found to be the most common mosaic gene in both the human and pig faecal samples tested and was present in almost as many samples tested as the non-mosaic tet(O) and tet(W) genes.[21] In contrast, mosaic genes have not yet been reported in faecal samples from bovine and ovine origin or in human saliva.[21] Why they are predominantly found in pigs while as yet unreported in other animals is not immediately clear, though the extensive use of tetracyclines in the swine industry[3,30,31] may have contributed to their selection.

Draft genome analysis

The advent of high-throughput genomic sequencing has led to an increase in the number of genomes being deposited in sequence databases. Many contain tetracycline resistance genes that are generically labelled simply as ‘tetracycline resistance protein’ or as ‘tet(M)-like’, the designation of which may be a result of automated annotation pipelines. A preliminary search of the NCBI nucleotide database, using tet(O) (accession number Y07780) as the query, found that some of these generically labelled tetracycline resistance genes gave a partial match to tet(O). Further examination indicates that some are as yet uncharacterized and unreported mosaic genes, which have been further defined for this review using the nucleotide sequence to determine the crossover points. For example, the tet(M)-like gene (accession number NZ_AUJS01000017, location 41 626–43 545 bp) in the draft genome of Dorea longicatena AGR2136 from a human faecal sample appears to be a previously unreported variant of tet(O/32/O) (Figure 1). Furthermore, the tetracycline resistance genes present in Campylobacter jejuni subspecies jejuni 2008-894, Campylobacter coli 202/04, C. coli 317/04 (accession numbers AIOQ01000025, AINH01000038 and NZ_AINJ01000054, respectively) and Roseburia intestinalis XB6B4 (accession number FP929050) are also structurally novel variants of tet(O/32/O) (Figure 1). The three mosaic genes present in the Campylobacter spp. are identical to each other, while that in R. intestinalis is different. Taking into account these newly defined genes, the total number of mosaic genes reported increases from 30 to 35 (not including those identified via PCR amplification only; Table 1) and suggests that other generically labelled tetracycline resistance genes present in the database [e.g. those labelled as tet(M)-like] could be further classified, helping to understand mosaic gene proliferation and diversity.

Conclusions

Our knowledge of the mosaic RPP gene group is steadily increasing since their discovery in 2003, with the majority derived from tet(O), tet(W) and tet(32) and others deriving from tet(M) and tet(S). It is clear that these genes are being under-reported both in terms of experimental detection and also within genomic data. Further work and increased attention on mosaic RPP genes is important if we are to understand the evolutionary selective pressures driving their fixation in bacterial populations and the subsequent effects on resistance and mobile genetic element evolution within their host.

Transparency declarations

None to declare.
  34 in total

1.  "tet(U)" is not a tetracycline resistance determinant.

Authors:  Jamie A Caryl; Georgina Cox; Stefan Trimble; Alex J O'Neill
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

2.  Hybrid tet genes and tet gene nomenclature: request for opinion.

Authors:  Thad B Stanton; Samuel B Humphrey; Karen P Scott; Harry J Flint
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Mosaic tetracycline resistance genes are widespread in human and animal fecal samples.

Authors:  Andrea J Patterson; Marco T Rincon; Harry J Flint; Karen P Scott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

4.  Distribution of specific tetracycline and erythromycin resistance genes in environmental samples assessed by macroarray detection.

Authors:  Andrea J Patterson; Roberto Colangeli; Patrizia Spigaglia; Karen P Scott
Journal:  Environ Microbiol       Date:  2007-03       Impact factor: 5.491

5.  Reported antibiotic use in 90 swine farms in Alberta.

Authors:  Andrijana Rajić; Richard Reid-Smith; Anne E Deckert; Catherine E Dewey; Scott A McEwen
Journal:  Can Vet J       Date:  2006-05       Impact factor: 1.008

6.  Characterization of a Streptococcus suis tet(O/W/32/O)-carrying element transferable to major streptococcal pathogens.

Authors:  Claudio Palmieri; Gloria Magi; Marina Mingoia; Patrizia Bagnarelli; Sandro Ripa; Pietro E Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

7.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

8.  Isolation of tetracycline-resistant Megasphaera elsdenii strains with novel mosaic gene combinations of tet(O) and tet(W) from swine.

Authors:  Thaddeus B Stanton; Samuel B Humphrey
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

9.  Prevalence and molecular characterization of tetracycline resistance in Enterococcus isolates from food.

Authors:  Geert Huys; Klaas D'Haene; Jean-Marc Collard; Jean Swings
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

10.  Diverse tetracycline resistance genotypes of Megasphaera elsdenii strains selectively cultured from swine feces.

Authors:  Thaddeus B Stanton; Jennifer S McDowall; Mark A Rasmussen
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

View more
  11 in total

1.  Prevalence of Potentially Pathogenic Antibiotic-Resistant Aeromonas spp. in Treated Urban Wastewater Effluents versus Recipient Riverine Populations: a 3-Year Comparative Study.

Authors:  Troy Skwor; Sarah Stringer; Jason Haggerty; Jenilee Johnson; Sarah Duhr; Mary Johnson; Megan Seckinger; Maggie Stemme
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

2.  A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078.

Authors:  Kate E Dingle; Xavier Didelot; T Phuong Quan; David W Eyre; Nicole Stoesser; Charis A Marwick; John Coia; Derek Brown; Sarah Buchanan; Umer Z Ijaz; Cosmika Goswami; Gill Douce; Warren N Fawley; Mark H Wilcox; Timothy E A Peto; A Sarah Walker; Derrick W Crook
Journal:  mBio       Date:  2019-03-12       Impact factor: 7.867

3.  Whole genome-based characterisation of antimicrobial resistance and genetic diversity in Campylobacter jejuni and Campylobacter coli from ruminants.

Authors:  Medelin Ocejo; Beatriz Oporto; José Luis Lavín; Ana Hurtado
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

4.  PCR-Based Analysis of ColE1 Plasmids in Clinical Isolates and Metagenomic Samples Reveals Their Importance as Gene Capture Platforms.

Authors:  Manuel Ares-Arroyo; Cristina Bernabe-Balas; Alfonso Santos-Lopez; Maria R Baquero; Kashi N Prasad; Dolores Cid; Carmen Martin-Espada; Alvaro San Millan; Bruno Gonzalez-Zorn
Journal:  Front Microbiol       Date:  2018-03-16       Impact factor: 5.640

5.  ICESag37, a Novel Integrative and Conjugative Element Carrying Antimicrobial Resistance Genes and Potential Virulence Factors in Streptococcus agalactiae.

Authors:  Kaixin Zhou; Lianyan Xie; Lizhong Han; Xiaokui Guo; Yong Wang; Jingyong Sun
Journal:  Front Microbiol       Date:  2017-10-05       Impact factor: 5.640

6.  Antibiotic Resistance Is Associated with Integrative and Conjugative Elements and Genomic Islands in Naturally Circulating Streptococcus pneumoniae Isolates from Adults in Liverpool, UK.

Authors:  Elissavet Nikolaou; Alasdair T M Hubbard; João Botelho; Taylor A M Marschall; Daniela M Ferreira; Adam P Roberts
Journal:  Genes (Basel)       Date:  2020-06-06       Impact factor: 4.096

7.  Effect of tetracycline treatment regimens on antibiotic resistance gene selection over time in nursery pigs.

Authors:  Kaare Græsbøll; Inge Larsen; Julie Clasen; Anna Camilla Birkegård; Jens Peter Nielsen; Lasse Engbo Christiansen; John Elmerdahl Olsen; Øystein Angen; Anders Folkesson
Journal:  BMC Microbiol       Date:  2019-12-02       Impact factor: 3.605

Review 8.  Acinetobacter baumannii Antibiotic Resistance Mechanisms.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Zoi Dorothea Pana; Athanasios Tragiannidis
Journal:  Pathogens       Date:  2021-03-19

Review 9.  Ribosome Protection Proteins-"New" Players in the Global Arms Race with Antibiotic-Resistant Pathogens.

Authors:  Rya Ero; Xin-Fu Yan; Yong-Gui Gao
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

10.  A Ternary Copper (II) Complex with 4-Fluorophenoxyacetic Acid Hydrazide in Combination with Antibiotics Exhibits Positive Synergistic Effect against Salmonella Typhimurium.

Authors:  Guilherme Paz Monteiro; Roberta Torres de Melo; Micaela Guidotti-Takeuchi; Carolyne Ferreira Dumont; Rosanne Aparecida Capanema Ribeiro; Wendell Guerra; Luana Munique Sousa Ramos; Drielly Aparecida Paixão; Fernanda Aparecida Longato Dos Santos; Dália Dos Prazeres Rodrigues; Peter Boleij; Patrícia Giovana Hoepers; Daise Aparecida Rossi
Journal:  Antibiotics (Basel)       Date:  2022-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.